查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539298

经导管心臟瓣膜置换·修復市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2033年

Transcatheter Heart Valve Replacement Repair Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 231 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球经导管心臟瓣膜置换和修復 (TAVR) 市场的深入研究报告，详细介绍了市场动态，包括驱动因素、趋势、机会和课题。本报告旨在提供对市场结构和未来前景的全面了解，特别是心血管医疗器材产业的利害关係人。

主要的洞察

  • 全球市场收入（2022 年）：84 亿美元
  • 预计市场价值（2033 年）：255 亿美元
  • 全球市场成长率（2022-2033 年复合年增长率）：13.1%

TAVR 的全球市场 - 报告范围：

TAVR 市场专注于用于更换和修復心臟瓣膜的设备和技术的生产和分销，特别是用于患有严重主动脉瓣狭窄和其他心血管疾病的患者。该市场的推动因素包括心血管疾病的日益普及、微创手术的日益普及以及 TAVR 产品的持续技术进步。

推动市场成长的因素：

TAVR 产品技术不断进步，心血管疾病盛行率不断上升

TAVR 市场的关键驱动因素之一是经导管主动脉瓣置换 (TAVR) 设备的持续技术进步。该公司正在开发第二代、更耐用的 TAVR 设备，以减少严重主动脉瓣狭窄患者的免疫排斥反应。正如最近的几项研究所证明的那样，这些新设备具有显着的安全优势，包括降低瓣週逆流、瓣膜栓塞和其他出血事件的发生率。

先进的影像技术在改善 TAVR 手术期间的决策方面也发挥着重要作用。这些技术创新预计将为市场繁荣创造有利可图的机会，持续的技术发展将推动 TAVI（经导管主动脉瓣植入术）和 TAVR 产品的未来成长。

心血管疾病（CVD）盛行率的上升是推动 TAVR 市场成长的另一个关键因素。据世界卫生组织 (WHO) 称，心血管疾病是全球第一大死因，估计每年有 1,790 万人死亡。由于心臟病发作和中风占 CVD 死亡人数的五分之四以上，对 TAVR 等有效瓣膜置换手术的需求预计将增加，并成为市场扩张的驱动力。

市场课题

高成本与监理课题

儘管成长前景广阔，但 TAVR 市场仍面临一些课题。 TAVR 手术和设备的高成本可能是广泛采用的主要障碍，特别是在医疗预算有限的低收入和中等收入国家。此外，TAVR 设备的监管环境很复杂，新产品上市前需要严格的审批流程。克服这些监管课题既耗时又昂贵，可能会减缓市场成长。

此外，虽然技术进步推动市场向前发展，但它们也需要大量的研发投资。公司必须不断创新才能保持竞争力，这可能会导致资源紧张并影响获利能力，特别是对于小市场中的公司。

本报告解决的关键问题

  • 推动全球 TAVR 市场成长的关键因素有哪些？
  • 哪些消费者群体正在推动 TAVR 的采用？
  • 技术进步如何影响竞争格局？
  • 谁是全球 TAVR 市场的主要参与者？
  • 全球 TAVR 市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制
  • 蕴藏事项·除外事项

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 主要成功因素

  • 采用率/使用情形分析 - 各地区
  • 技术评估
  • 产品的USP分析
  • 法规情境
  • 疾病流行病学
  • 偿付的形势
  • 最近产品认证/销售
  • PESTEL分析
  • 波特分析
  • 价值链分析

第5章 市场背景

  • 宏观经济要素
  • 预测要素 - 相关性及影响
  • 市场动态

第6章 COVID-19危机分析

  • COVID-19及影响分析
    • 各产品
    • 各适应症
    • 各终端用户
    • 各地区
  • 2024年的市场情境

第7章 全球市场的需求(金额10亿美元)分析

  • 过去的市场金额(10亿美元)分析，2019年～2023年
  • 现在及未来市场金额(10亿美元)的分析与预测，2024年～2033年
    • 与前一年同期比较成长趋势分析
    • 绝对额的机会分析

第8章 全球市场分析:各产品

  • 简介/主要调查结果
  • 过去的市场规模(10亿美元)分析:各产品，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各产品，2024年～2033年
    • 经导管主动脉瓣置换术(TAVR)设备
    • 经导管二尖瓣瓣膜修復(TMVR)设备
  • 市场魅力分析:各产品

第9章 全球市场分析:各适应症

  • 简介/主要调查结果
  • 过去的市场规模(10亿美元)分析:各适应症，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各适应症，2024年～2033年
    • 重度的主动脉阀狭窄症
    • 阀门界内阀门手术(生物学心臟瓣膜不全)
    • 主动脉阀逆流症
  • 市场魅力分析:各适应症

第10章 全球市场分析:各终端用户

  • 简介/主要调查结果
  • 过去的市场规模(10亿美元)分析:各终端用户，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各终端用户，2024年～2033年
    • 医院
    • 独立了的心导管检验室
    • 门诊病人手术中心
  • 市场魅力分析:各终端用户

第11章 全球市场分析:各地区

  • 简介
  • 过去的市场规模(10亿美元)的分析:各地区，2019年～2023年
  • 现在及未来市场规模(10亿美元)的分析与预测:各地区，2024年～2033年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东·非洲(MEA)
  • 市场魅力分析:各地区

第12章 北美市场分析

第13章 南美市场分析

第14章 欧洲市场分析

第15章 东亚市场分析

第16章 南亚市场分析

第17章 大洋洲市场

第18章 中东·非洲(MEA)市场分析

第19章 市场结构分析

  • 市场分析:各企业层级
  • 主要企业的市场占有率分析
  • 市场影响分析

第20章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争的详细资讯
    • Abbott
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • JenaValve Technology, Inc.
    • Meril Life Sciences
    • Sahajanand Medical Technologies Limited
    • MicroPort Scientific Corporation
    • Venus Medtech(Hangzhou)Inc.
    • Suzhou Jiecheng Medical Technology Co. Ltd.
    • Peijia Medical Limited
    • Blue Sail Medical Co., Ltd.

第21章 所使用的前提条件与缩写

第22章 调查手法

简介目录
Product Code: PMRREP11167

Persistence Market Research has recently published an in-depth report on the global transcatheter heart valve replacement and repair (TAVR) market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the cardiovascular medical device industry.

Key Insights:

  • Global Market Revenue (2022): US$ 8.4 Billion
  • Estimated Market Value (2033): US$ 25.5 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 13.1%

Global TAVR Market - Report Scope:

The TAVR market focuses on the production and distribution of devices and technologies used in the replacement and repair of heart valves, particularly for patients suffering from severe aortic stenosis and other cardiovascular diseases. This market is driven by the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and continuous technological advancements in TAVR products.

Market Growth Drivers:

Continuous Technological Advancements in TAVR Products Coupled with Increasing Prevalence of Cardiovascular Diseases

One of the primary drivers of the TAVR market is the continuous technological advancements in transcatheter aortic valve replacement (TAVR) devices. Companies are developing second-generation TAVR devices with enhanced durability to reduce immune rejections in patients with severe aortic stenosis. These newer devices offer significant safety benefits, including lower rates of paravalvular regurgitation, valve embolization, and other bleeding events, as evidenced by several recent studies.

Advanced imaging technologies are also playing a crucial role in improving decision-making during TAVR procedures. These innovations are expected to create lucrative opportunities for the market to flourish, with ongoing technological developments driving future growth in TAVI (transcatheter aortic valve implantation) and TAVR products.

The rising prevalence of cardiovascular diseases (CVDs) is another significant factor fueling the growth of the TAVR market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths per year. With heart attacks and strokes making up more than four out of every five CVD deaths, the demand for effective valve replacement surgeries, such as TAVR, is expected to rise, driving market expansion.

Market Challenges:

High Costs and Regulatory Challenges

Despite the promising growth prospects, the TAVR market faces several challenges. The high cost of TAVR procedures and devices can be a significant barrier to widespread adoption, particularly in low- and middle-income countries where healthcare budgets are limited. Additionally, the regulatory landscape for TAVR devices is complex, with stringent approval processes required before new products can be introduced to the market. Navigating these regulatory challenges can be time-consuming and costly, potentially slowing down market growth.

Furthermore, while technological advancements are driving the market forward, they also require substantial investment in research and development. Companies must continuously innovate to stay competitive, which can strain resources and impact profitability, particularly for smaller players in the market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global TAVR market?
  • Which consumer segments are leading the adoption of TAVR procedures?
  • How are technological advancements influencing the competitive landscape?
  • Who are the key players in the global TAVR market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market, including Edwards Lifesciences, Medtronic, and Boston Scientific Corporation, are focusing on product innovation, strategic partnerships, and expanding their market presence in emerging economies. These companies are heavily investing in research and development to create next-generation TAVR devices that offer improved safety, durability, and patient outcomes. Collaborations with healthcare providers and academic institutions are enhancing market credibility and driving the adoption of new technologies.

Additionally, the market is seeing a trend towards the integration of advanced imaging and diagnostic tools with TAVR procedures, further improving the precision and outcomes of valve replacement surgeries. As the market continues to grow, companies are expected to explore new opportunities in minimally invasive cardiovascular procedures and expand their product portfolios to cater to a broader patient population.

Key Companies Profiled:

  • Abbott
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Boston Scientific Corporation
  • JenaValve Technology, Inc.
  • Meril Life Sciences
  • Sahajanand Medical Technologies Limited
  • MicroPort Scientific Corporation
  • Venus Medtech (Hangzhou) Inc.
  • Suzhou Jiecheng Medical Technology Co. Ltd.
  • Peijia Medical Limited
  • Blue Sail Medical Co., Ltd.

Key Segments Covered in Transcatheter Heart Valve Replacement Repair Industry Research

Product:

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Repair (TMVR)

Indication:

  • Severe Aortic Valve Stenosis
  • Valve-in-Valve Procedures (Failed Bioprosthesis)
  • Aortic Regurgitation

End User:

  • Hospitals
  • Independent Cardiac Catheterization Labs
  • Ambulatory Surgical Centres

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - By Region
  • 4.2. Technology Assessment
  • 4.3. Product USP Analysis
  • 4.4. Regulatory Scenario
  • 4.5. Disease Epidemiology
  • 4.6. Reimbursement Landscape
  • 4.7. Recent Product Approvals/Launches
  • 4.8. PESTEL Analysis
  • 4.9. Porter's Analysis
  • 4.10. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Cardiac Surgery Devices Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Cardiovascular Diseases
    • 5.2.2. Demand for Minimally Invasive Procedures
    • 5.2.3. Growing Number of Patients Suffering from Aortic Stenosis
    • 5.2.4. Increasing Product Approvals
    • 5.2.5. Technological Advancements
    • 5.2.6. Prevalence of Obesity
    • 5.2.7. Increasing Surgical Procedural Volume
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
    • 8.3.1. Transcatheter Aortic Valve Replacement (TAVR) Devices
      • 8.3.1.1. Self - Expandable Transcatheter Aortic Valves
      • 8.3.1.2. Balloon-Expandable Transcatheter Aortic Valves
      • 8.3.1.3. "Mechanically Expanded Transcatheter Aortic Valves"
    • 8.3.2. Transcatheter Mitral Valve Repair (TMVR) Devices
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Indication, 2024-2033
    • 9.3.1. Severe Aortic Valve Stenosis
    • 9.3.2. Valve-in-Valve Procedures (Failed Bioprosthesis)
    • 9.3.3. Aortic Regurgitation
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Independent Cardiac Catheterization Labs
    • 10.3.3. Ambulatory Surgical Centers
  • 10.4. Market Attractiveness Analysis, by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Indication
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Product
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By End User
    • 12.7.2. Canada Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Product
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Product
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By End User
    • 13.7.2. Brazil Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Product
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By End User
    • 13.7.3. Argentina Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Product
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By End User
    • 14.7.2. Italy Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By End User
    • 14.7.3. France Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Product
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By End User
    • 14.7.4. U.K. Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Product
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By End User
    • 14.7.5. Spain Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Product
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By End User
    • 14.7.6. BENELUX Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Product
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By End User
    • 14.7.7. Russia Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Product
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Indication
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By End User
    • 15.7.2. Japan Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By End User
    • 15.7.3. South Korea Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By End User
    • 16.7.2. Indonesia Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By End User
    • 16.7.3. Malaysia Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By End User
    • 16.7.4. Thailand Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Indication
        • 16.7.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By End User
    • 17.7.2. New Zealand Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Indication
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By End User
    • 18.7.2. Turkiye Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By End User
    • 18.7.3. South Africa Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By End User
    • 18.7.4. North Africa Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Indication
        • 18.7.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Abbott
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. Edwards Lifesciences Corporation
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Medtronic plc
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Boston Scientific Corporation
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. JenaValve Technology, Inc.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Meril Life Sciences
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Sahajanand Medical Technologies Limited
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. MicroPort Scientific Corporation
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Venus Medtech (Hangzhou) Inc.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Product Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Product Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Peijia Medical Limited
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Product Strategy
        • 20.3.11.6.3. Channel Strategy
    • 20.3.12. Blue Sail Medical Co., Ltd.
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Key Financials
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategy Overview
        • 20.3.12.6.1. Marketing Strategy
        • 20.3.12.6.2. Product Strategy
        • 20.3.12.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology